Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.
2.

Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.

Flood TA, Schieda N, Keefe DT, Breau RH, Morash C, Hogan K, Belanger EC, Mai KT, Robertson SJ.

Virchows Arch. 2016 Sep;469(3):313-9. doi: 10.1007/s00428-016-1981-2. Epub 2016 Jul 10.

PMID:
27394432
3.

Downgrading of biopsy based Gleason score in prostatectomy specimens.

Treurniet KM, Trudel D, Sykes J, Evans AJ, Finelli A, Van der Kwast TH.

J Clin Pathol. 2014 Apr;67(4):313-8. doi: 10.1136/jclinpath-2012-201323. Epub 2013 Oct 29.

PMID:
24403214
4.

Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.

Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS.

BJU Int. 2009 Jan;103(1):43-8. doi: 10.1111/j.1464-410X.2008.08059.x. Epub 2008 Sep 8.

5.

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.

Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.

BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.

6.

Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.

Huang CC, Kong MX, Zhou M, Rosenkrantz AB, Taneja SS, Melamed J, Deng FM.

Am J Surg Pathol. 2014 Aug;38(8):1096-101. doi: 10.1097/PAS.0000000000000235.

PMID:
24832163
7.

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.

King CR, McNeal JE, Gill H, Presti JC Jr.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):386-91.

PMID:
15145152
8.

Elevated fatty acid synthase expression in prostate needle biopsy cores predicts upgraded Gleason score in radical prostatectomy specimens.

Hamada S, Horiguchi A, Kuroda K, Ito K, Asano T, Miyai K, Iwaya K.

Prostate. 2014 Jan;74(1):90-6. doi: 10.1002/pros.22732. Epub 2013 Sep 21.

PMID:
24108439
9.

Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.

Keefe DT, Schieda N, El Hallani S, Breau RH, Morash C, Robertson SJ, Mai KT, Belanger EC, Flood TA.

Virchows Arch. 2015 Oct;467(4):437-42. doi: 10.1007/s00428-015-1809-5. Epub 2015 Jul 31.

PMID:
26229020
10.

PI-RADS version 2 for prediction of pathological downgrading after radical prostatectomy: a preliminary study in patients with biopsy-proven Gleason Score 7 (3+4) prostate cancer.

Woo S, Kim SY, Lee J, Kim SH, Cho JY.

Eur Radiol. 2016 Oct;26(10):3580-7. doi: 10.1007/s00330-016-4230-9. Epub 2016 Feb 4.

PMID:
26847042
11.

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.

Tilki D, Schlenker B, John M, Buchner A, Stanislaus P, Gratzke C, Karl A, Tan GY, Ergün S, Tewari AK, Stief CG, Seitz M, Reich O.

Urol Oncol. 2011 Sep-Oct;29(5):508-14. doi: 10.1016/j.urolonc.2009.07.003. Epub 2009 Oct 17.

PMID:
19837614
12.

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

Freedland SJ, Kane CJ, Amling CL, Aronson WJ, Terris MK, Presti JC Jr; SEARCH Database Study Group.

Urology. 2007 Mar;69(3):495-9.

13.

Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.

Fanning DM, Kay E, Fan Y, Fitzpatrick JM, Watson RW.

BJU Int. 2010 Mar;105(5):631-5. doi: 10.1111/j.1464-410X.2009.08810.x. Epub 2009 Sep 3.

14.

Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer.

Gondo T, Poon BY, Matsumoto K, Bernstein M, Sjoberg DD, Eastham JA.

BJU Int. 2015 Jan;115(1):81-6. doi: 10.1111/bju.12769. Epub 2014 Aug 13.

15.

Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.

Kır G, Seneldir H, Gumus E.

Ann Diagn Pathol. 2016 Feb;20:48-51. doi: 10.1016/j.anndiagpath.2015.10.013. Epub 2015 Dec 2.

PMID:
26750655
16.

Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.

Berg KD, Røder MA, Brasso K, Vainer B, Iversen P.

Scand J Urol. 2014 Apr;48(2):168-76. doi: 10.3109/21681805.2013.821628. Epub 2013 Jul 29.

PMID:
23889119
17.

Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.

Ellis CL, Partin AW, Han M, Epstein JI.

J Urol. 2013 Dec;190(6):2068-73. doi: 10.1016/j.juro.2013.05.056. Epub 2013 May 30.

PMID:
23727307
18.

Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings.

Karram S, Trock BJ, Netto GJ, Epstein JI.

Am J Surg Pathol. 2011 Sep;35(9):1351-5. doi: 10.1097/PAS.0b013e3182217b79.

PMID:
21836493
19.

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy.

Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM.

BJU Int. 2012 Oct;110(8):1122-8. doi: 10.1111/j.1464-410X.2012.10986.x. Epub 2012 Feb 28.

20.

Supplemental Content

Support Center